Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome

References

[1] Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute: American Heart Association: World Heart Federation; International Atherosclerosis Society; and International Association for the study of Obesity. Circulation. 2009;120:1640–5.10.1161/CIRCULATIONAHA.109.192644Suche in Google Scholar PubMed

[2] Ford ES, Li C, Zhao G. Prevalence and correlations of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010;2:180–93.10.1111/j.1753-0407.2010.00078.xSuche in Google Scholar PubMed

[3] Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43:1–23.10.1016/j.ecl.2013.09.009Suche in Google Scholar PubMed

[4] Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–25.10.1161/01.CIR.0000132467.45278.59Suche in Google Scholar PubMed

[5] Jialal I, Devaraj S, Adams-Huet B, Chen X, Kaur H. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab. 2012;97:E1844–50.10.1210/jc.2012-2498Suche in Google Scholar PubMed

[6] Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96:E1782–8.10.1210/jc.2011-1577Suche in Google Scholar PubMed PubMed Central

[7] Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35:900–4.10.2337/dc11-2375Suche in Google Scholar PubMed PubMed Central

[8] Jialal I, Devaraj S, Rajamani U. Dysregulation of monocyte biology in metabolic syndrome. Expert Rev Endocrinol Metab. 2014;9:213–21.10.1586/17446651.2014.890046Suche in Google Scholar PubMed

[9] Jialal I, Adams-Huet B, Pahwa R. Selective increase in monocyte p38 mitogen-activated protein kinase activity in metabolic syndrome. Diab Vasc Dis Res. 2016;13:93–6.10.1177/1479164115607829Suche in Google Scholar PubMed

[10] Gurung P, Moussa K, Adams-Huet B, Devaraj S, Jialal I. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis. Am J Physiol Endocrinol Metab. 2019;316:E504–9.10.1152/ajpendo.00462.2018Suche in Google Scholar PubMed

[11] Reddy P, Lent-Schochet D, Ramakrishnan N, McLaughlin M, Jialal I. Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes. Clinica Chimica Acta. 2019;496:35–44.10.1016/j.cca.2019.06.019Suche in Google Scholar PubMed

[12] Babio N, Ibarrola-Jurado N, Bulló M, Martínez-González MÁ, Wärnberg J, Salaverría I, et al. White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. PLoS One. 2013;8:e58354.10.1371/journal.pone.0058354Suche in Google Scholar PubMed PubMed Central

[13] Lao XQ, Neil-Thomas G, Jiang C, Zhang W, Adab P, Lam TH, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank cohort study. Atherosclerosis. 2008;201:418–24.10.1016/j.atherosclerosis.2007.12.053Suche in Google Scholar PubMed

[14] Sun S, Wu H, Zhang Q, Wang C, Guo Y, Du H, et al. Subnormal peripheral blood leukocyte counts are related to the lowest prevalence and incidence of metabolic syndrome: Tianjin chronic low-grade systemic inflammation and health cohort study. Mediators Inflamm. 2014;2014:1–12.10.1155/2014/412386Suche in Google Scholar PubMed PubMed Central

[15] AbuZayed R, Bulatova N, Kasabri V, Suyagh M, Halaseh L, AlAlawi S. Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes. Horm Mol Biol Clin Investig. 2019;37:1–8.10.1515/hmbci-2018-0052Suche in Google Scholar PubMed

[16] Kim DJ, Noh JH, Lee BW, Choi YH, Chung JH, Min YK, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci. 2008;23:193–8.10.3346/jkms.2008.23.2.193Suche in Google Scholar PubMed PubMed Central

[17] Ryder E, Diez-Ewald M, Mosquera J, Fernandez E, Pedreanez A, Vargas R, et al. Association of obesity with leukocyte count in obese individuals without metabolic syndrome. Diabetes Metab Syndr. 2014;8:197–204.10.1016/j.dsx.2014.09.002Suche in Google Scholar PubMed

[18] Oliveira CC, Roriz AK, Ramos LB, Neto MG. Blood count parameters as a marker for metabolic syndrome in older adults. Exp Gerontol. 2017;96:123–6.10.1016/j.exger.2017.06.018Suche in Google Scholar PubMed

[19] Abdel-Moneim A, Mahmoud B, Sultan EA, Mahmoud R. Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients. Diabetes Metab Syndr. 2019;13:874–80.10.1016/j.dsx.2018.12.016Suche in Google Scholar PubMed

[20] Meng G, Zhu Q, Shao J, Zhang Q, Liu L, Wu H, et al. Comparing the diagnostic ability of inflammatory markers in metabolic syndrome. Clin Chim Acta. 2017;475:1–6.10.1016/j.cca.2017.09.023Suche in Google Scholar PubMed

[21] Kaur H, Adams-Huet B, Smith G, Jialal I. Increases neutrophil count in nascent metabolic syndrome. Metatbol Syndr Relat Discord. 2013;11:128–31.10.1089/met.2012.0179Suche in Google Scholar PubMed

[22] Adams-Huet B, Jialal I. The neutrophil count is superior to the neutrophil/lymphocyte ratio as a biomarker of inflammation in nascent metabolic syndrome. Ann Clin Biochem. 2019;56:715–6.10.1177/0004563219866221Suche in Google Scholar PubMed

[23] Pirillo A, Catapano AL, Norata GD. Biological consequences of dysfunctional HDL. Curr Med Chem. 2019;26:1644–64.10.2174/0929867325666180530110543Suche in Google Scholar PubMed

[24] Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384:618–25.10.1016/S0140-6736(14)61217-4Suche in Google Scholar PubMed

[25] Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55:2319–26.10.1007/s00125-012-2598-xSuche in Google Scholar PubMed

[26] Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257:167–75.10.1111/j.1365-2796.2004.01426.xSuche in Google Scholar PubMed

[27] Jialal I, Devaraj S, Singh U, Huet BA. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis. 2010;211:297–302.10.1016/j.atherosclerosis.2010.01.036Suche in Google Scholar PubMed PubMed Central

[28] Jialal I, Inn M, Siegel D, Devaraj S. Underestimation of low density lipoprotein-cholesterol with the Friedwald Equation versus a direct homogenous low density lipoprotein-cholesterol assay. Lab Med. 2017;48:220–4.10.1093/labmed/lmx023Suche in Google Scholar PubMed

[29] DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.10.2307/2531595Suche in Google Scholar

[30] Vahit D, Akboga MK, Samet Y, Huseyin E. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark Med. 2017;11:535–40.10.2217/bmm-2016-0380Suche in Google Scholar PubMed

[31] Uslu AU, Sekin Y, Tarhan G, Canakci N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hermost. 2018;24:828–33.10.1177/1076029617741362Suche in Google Scholar PubMed PubMed Central

[32] Nijhuis J, Rensen SS, Slaats Y, Van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring). 2009;17:2014–8.10.1038/oby.2009.113Suche in Google Scholar PubMed

[33] Brotfain E, Hadad N, Shapira Y, Avinoah E, Zlotnik A, Raichel L, et al. Neutrophil functions in morbidly obese subjects. Clin Exp Immunol. 2015;181:156–63.10.1111/cei.12631Suche in Google Scholar PubMed PubMed Central

[34] Talukdar S, Oh DY, Bandyopadhyay G, Li D, Xu J, McNelis J, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012;18:1407–12.10.1038/nm.2885Suche in Google Scholar PubMed PubMed Central

[35] Doring Y, Drechsler M, Soehnlein O, Webber C. Neutrophils in atherosclerosis: from mice to man. Arterioscler Thromb Vasc Biol. 2015;35:288–95.10.1161/ATVBAHA.114.303564Suche in Google Scholar PubMed

[36] Moschonas IC, Tselepis AD. The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. Atherosclerosis. 2019;288:9–16.10.1016/j.atherosclerosis.2019.06.919Suche in Google Scholar PubMed